NCT06887972View on ClinicalTrials.gov

A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

December 18, 2025

Study Completion Date

January 1, 2026

Conditions
Acute Pain
Interventions
DRUG

Suzetrigine

Tablets for oral administration.

Trial Locations (4)

30331

RECRUITING

Atlanta Center for Medical Research, Atlanta

77043

RECRUITING

Memorial Hermann Village, Houston

84107

RECRUITING

JBR Clinical Research, Salt Lake City

Texas

RECRUITING

"HD Research LLC , First Surgical Hospital"

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY